Metraipolis › archive › dc_7e803631f254

GV21 enables ultrasound molecular imaging of tumor cell-associated VEGFR2 for early therapy assessment — Europe PMC PMID:42761203

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42761203
DOI
10.1016/j.mtbio.2026.103659
License (as archived)
solo-consultazione
Archived
2026-10-16T00:16:06.053Z
SHA-256 of the archived text
db7756a01aa245fa2f3798f1384743fa10a5cd453de222b6436429ea205355f8
Stable URL of this page
https://metraipolis.com/documento/dc_7e803631f254

How to cite

GV21 enables ultrasound molecular imaging of tumor cell-associated VEGFR2 for early therapy assessment — Europe PMC PMID:42761203 — Europe PMC (en), https://europepmc.org/article/MED/42761203 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e803631f254 (Metraipolis archive dc_7e803631f254, sha256 db7756a01aa245fa2f3798f1384743fa10a5cd453de222b6436429ea205355f8)
BibTeX
@misc{dc7e803631f254,
  title = {GV21 enables ultrasound molecular imaging of tumor cell-associated VEGFR2 for early therapy assessment — Europe PMC PMID:42761203},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42761203},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e803631f254; sha256 db7756a01aa245fa2f3798f1384743fa10a5cd453de222b6436429ea205355f8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42761203. Agents can read the archived copy with the MCP tool read_document.